Clinical Trial: ECOG-ACRIN EA3202

ECOG-ACRIN EA3202

Status: New, Open

A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers